NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -1.55% | -25.83% | -44.21% | -53.75% | 288.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.12% | -16.64% | -45.21% | -47.51% | 220.78% |
| Operating Income | 10.12% | 16.64% | 45.21% | 47.51% | -220.78% |
| Income Before Tax | -0.48% | 21.87% | 22.95% | 41.28% | -17.90% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.48% | 21.87% | 22.95% | 41.28% | -17.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -0.48% | 21.87% | 22.95% | 41.28% | -17.90% |
| EBIT | 10.12% | 16.64% | 45.21% | 47.51% | -220.78% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2.50% | 22.37% | 23.08% | 41.76% | -17.65% |
| Normalized Basic EPS | 0.00% | 22.92% | 24.24% | 42.11% | -19.05% |
| EPS Diluted | -2.50% | 22.37% | 23.08% | 41.76% | -17.65% |
| Normalized Diluted EPS | 0.00% | 22.92% | 24.24% | 42.11% | -19.05% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
